FY2025 EPS Estimate for Teladoc Health Decreased by Analyst

Teladoc Health, Inc. (NYSE:TDOC) – Equities researchers at Zacks Research cut their FY2025 earnings per share estimates for shares of Teladoc Health in a research note issued to investors on Tuesday, February 17th. Zacks Research analyst Team now expects that the health services provider will post earnings of ($0.90) per share for the year, down from their previous estimate of ($0.83). Zacks Research has a “Hold” rating on the stock. The consensus estimate for Teladoc Health’s current full-year earnings is ($1.16) per share.

A number of other research analysts also recently weighed in on the stock. Bank of America decreased their target price on shares of Teladoc Health from $9.00 to $8.00 and set a “neutral” rating for the company in a research report on Tuesday, November 25th. Weiss Ratings restated a “sell (e+)” rating on shares of Teladoc Health in a research note on Monday, December 29th. Citigroup lowered their target price on Teladoc Health from $10.00 to $9.00 and set a “neutral” rating on the stock in a research report on Friday, January 9th. Barclays began coverage on Teladoc Health in a report on Tuesday, December 9th. They set an “equal weight” rating and a $8.50 target price on the stock. Finally, Evercore reduced their price target on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a research report on Thursday, October 30th. Three analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $9.12.

Teladoc Health Price Performance

NYSE TDOC opened at $4.75 on Friday. The firm’s 50 day moving average is $6.23 and its 200-day moving average is $7.27. The company has a quick ratio of 2.60, a current ratio of 2.70 and a debt-to-equity ratio of 0.71. The company has a market capitalization of $842.10 million, a PE ratio of -3.71 and a beta of 2.12. Teladoc Health has a 12-month low of $4.40 and a 12-month high of $12.69.

Insider Activity

In other Teladoc Health news, insider Carlos Nueno sold 3,897 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total transaction of $29,188.53. Following the transaction, the insider owned 27,175 shares of the company’s stock, valued at $203,540.75. The trade was a 12.54% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Fernando M. Rodrigues sold 4,209 shares of the firm’s stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $7.48, for a total value of $31,483.32. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 33,288 shares of company stock valued at $251,684 in the last 90 days. 0.58% of the stock is owned by company insiders.

Institutional Investors Weigh In On Teladoc Health

A number of large investors have recently added to or reduced their stakes in TDOC. Jupiter Asset Management Ltd. boosted its position in Teladoc Health by 293.9% during the fourth quarter. Jupiter Asset Management Ltd. now owns 3,860,076 shares of the health services provider’s stock worth $27,021,000 after purchasing an additional 2,880,008 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Teladoc Health by 23.8% in the third quarter. Dimensional Fund Advisors LP now owns 6,889,194 shares of the health services provider’s stock valued at $53,260,000 after purchasing an additional 1,325,106 shares during the period. Trexquant Investment LP acquired a new stake in shares of Teladoc Health during the 4th quarter worth about $9,156,000. Monaco Asset Management SAM boosted its holdings in shares of Teladoc Health by 159.2% during the 4th quarter. Monaco Asset Management SAM now owns 1,956,947 shares of the health services provider’s stock worth $13,699,000 after buying an additional 1,201,947 shares during the period. Finally, Allianz Asset Management GmbH boosted its holdings in shares of Teladoc Health by 189.2% during the 3rd quarter. Allianz Asset Management GmbH now owns 1,619,391 shares of the health services provider’s stock worth $12,518,000 after buying an additional 1,059,458 shares during the period. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.